COVID-19 vaccination coverage has progressed unevenly throughout the world. Moreover, 1.01 and 1.43 doses for each person are ...

On 1, Novavax, Inc. (NASDAQ:NVAX) and the U.K. Health Security Agency, representing the U.K. Secretary of State for Health ...

The XEC COVID-19 variant is poised to become the dominant variant worldwide. Now is a good time to get an updated COVID ...

Pfizer-BioNTech, Johnson and Johnson, and Moderna said their vaccines prevented severe illness and hospitalization in COVID-19 cases caused by the variant ... in June 2024 and rapidly spread ...

An opponent of vaccines who wrote social media posts urging violence against scientists, politicians and public health officials during the COVID-19 pandemic was sentenced Monday to five ...

An additional case of a new strain of mpox has been detected in Britain, bringing the total number of infections in the ...

The WHO also set up a scheme to help bring mpox vaccines, tests and treatments to the most vulnerable people in the world's poorest countries, similar to efforts during the COVID-19 pandemic.

Among the consequences of his term was the U.S.’ high Covid death rate (at least compared with Europe) as Trump abdicated his responsibility ... perhaps the country’s best-known disparager of vaccines ...

On July 3, 2024, BioNTech and Pfizer’s Omicron JN.1-adapted COVID-19 vaccine was approved by the European Commission (“EC”). Shortly following approval, the updated vaccines were made available to ...

Mr Kennedy is a prominent critic of vaccines, and has claimed childhood immunisation can cause autism. Last week, he said ...

Novavax, Inc. ( NASDAQ: NVAX) Q3 2024 Earnings Conference Call November 12, 2024 8:30 AM ET ...

Earlier in October, the European Commission approved Novavax's updated 2024-2025 Nuvaxovid COVID-19 Vaccine (recombinant, adjuvanted) (NVX-CoV2705), dispersion for injection, for use in ...